<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Zhao Y</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Radiumhemmets Forskningsfonder</funding><funding>Karolinska Institutet</funding><funding>Barncancerfonden</funding><funding>Vetenskapsr?det</funding><pubmed_abstract>Late diagnosis and refractory behavior toward current treatment protocols make pancreatic ductal adenocarcinoma (PDAC) one of the most difficult cancer forms to treat. The imaging-based approach plays an important role to identify potentially curable PDAC patients in high-risk groups at the early stage. In the present study, we developed a core-shell structured gold nanorod (AuNR) as a contrast agent for multimodal imaging and investigated its application for PDAC diagnosis. The composite nanoparticles composed of a AuNR core inside a layer of mesoporous silica that was then coated with a gadolinium oxide carbonate shell (AuNR-SiO2-Gd) are designed to be used in magnetic resonance imaging (MRI), X-ray computed tomography (CT), and photoacoustic imaging (PAI). A phantom study with the AuNR-</pubmed_abstract><journal>ACS applied materials &amp; interfaces</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7735668</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents.</pubmed_title><pmcid>PMC7735668</pmcid><funding_grant_id>2018-02377</funding_grant_id><funding_grant_id>PR2017-0083</funding_grant_id><funding_grant_id>161082</funding_grant_id><funding_grant_id>2017-00741</funding_grant_id><funding_grant_id>EXC 2056/390715994</funding_grant_id><pubmed_authors>Parak WJ</pubmed_authors><pubmed_authors>Hassan M</pubmed_authors><pubmed_authors>Oerther S</pubmed_authors><pubmed_authors>Muhammed M</pubmed_authors><pubmed_authors>Zheng W</pubmed_authors><pubmed_authors>He R</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Heuchel R</pubmed_authors><pubmed_authors>El-Sayed R</pubmed_authors><pubmed_authors>Brismar TB</pubmed_authors><pubmed_authors>Feliu N</pubmed_authors><pubmed_authors>Ye F</pubmed_authors><pubmed_authors>Dutta J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents.</name><description>Late diagnosis and refractory behavior toward current treatment protocols make pancreatic ductal adenocarcinoma (PDAC) one of the most difficult cancer forms to treat. The imaging-based approach plays an important role to identify potentially curable PDAC patients in high-risk groups at the early stage. In the present study, we developed a core-shell structured gold nanorod (AuNR) as a contrast agent for multimodal imaging and investigated its application for PDAC diagnosis. The composite nanoparticles composed of a AuNR core inside a layer of mesoporous silica that was then coated with a gadolinium oxide carbonate shell (AuNR-SiO2-Gd) are designed to be used in magnetic resonance imaging (MRI), X-ray computed tomography (CT), and photoacoustic imaging (PAI). A phantom study with the AuNR-</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2025-04-18T14:11:58.945Z</modification><creation>2025-04-07T00:13:00.466Z</creation></dates><accession>S-EPMC7735668</accession><cross_references><pubmed>33201660</pubmed><doi>10.1021/acsami.0c15430</doi></cross_references></HashMap>